#75 Strong Clinical Relevance
High-quality evidence with meaningful patient or clinical significance.
Elevated morning cortisol in frequent cannabis users may indicate chronic stress activation or hypothalamic-pituitary-adrenal axis dysregulation, which clinicians should assess when evaluating cannabis patients for anxiety, sleep disorders, or metabolic complications. This finding suggests that cannabis use frequency warrants consideration as a potential contributor to stress-related pathology, making it relevant for risk stratification and counseling in primary care and mental health settings. Understanding this physiological effect helps clinicians better inform patients about potential systemic consequences of regular cannabis use beyond traditional psychiatric or respiratory concerns.
This study found that frequent cannabis users demonstrate elevated morning cortisol levels compared to non-users, suggesting that regular cannabis consumption may alter hypothalamic-pituitary-adrenal axis function. Since cortisol awakening response is a validated marker of stress physiology and has been associated with various health outcomes including metabolic dysfunction and cardiovascular risk, this finding raises concerns about potential endocrine consequences of chronic cannabis use. The clinical relevance lies in the fact that patients with elevated morning cortisol may experience increased anxiety, sleep disruption, and metabolic complications, which could complicate existing conditions or contraindicate cannabis use in certain populations. Future research should investigate whether this cortisol elevation persists with cannabis cessation, whether it varies by route of administration or cannabinoid profile, and whether it contributes to adverse health outcomes in heavy users. Clinicians should consider inquiring about morning symptoms such as anxiety, insomnia, and metabolic changes in frequent cannabis users and may consider cortisol monitoring in patients with concerning presentations. For patients considering regular cannabis use or those currently using it frequently, discussing potential impacts on stress hormones and monitoring for related symptoms represents an important aspect of informed decision-making about cannabis in clinical practice.
💊 This cross-sectional finding of elevated morning cortisol in frequent cannabis users warrants cautious interpretation in clinical contexts, as elevated cortisol upon waking can reflect stress physiology, sleep disruption, or other lifestyle factors that may confound the association with cannabis use itself. While hypothalamic-pituitary-adrenal axis dysregulation is biologically plausible with chronic cannabinoid exposure, the direction of causality remains unclear—cannabis use may be a consequence of underlying stress rather than its cause, and frequency of use does not establish whether acute or chronic effects predominate. Clinicians should recognize that self-reported cannabis consumption patterns and timing relative to cortisol sampling, as well as potential differences in product potency and route of administration across users, represent important unmeasured variables that complicate interpretation. When counseling patients about regular cannabis use, particularly those with anxiety, sleep problems, or known stress-related conditions,
💬 Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
Have thoughts on this? Share it:
